Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Feb 15;203(4):524-525.
doi: 10.1164/rccm.202009-3664LE.

Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?

Jason Weatherald  1   2 , Athénaïs Boucly  3   4   5 , Laurent Savale  3   4   5 , Xavier Jaïs  3   4   5 , David Montani  3   4   5 , Marc Humbert  3   4   5 , Olivier Sitbon  3   4   5
Affiliations
Comment

Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?

Jason Weatherald et al. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment in

Comment on

  • Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension.
    Badagliacca R, D'Alto M, Ghio S, Argiento P, Bellomo V, Brunetti ND, Casu G, Confalonieri M, Corda M, Correale M, D'Agostino C, De Michele L, Galgano G, Greco A, Lombardi C, Manzi G, Mercurio V, Mulè M, Paciocco G, Papa S, Romeo E, Scelsi L, Stolfo D, Vitulo P, Naeije R, Vizza CD. Badagliacca R, et al. Am J Respir Crit Care Med. 2021 Feb 15;203(4):484-492. doi: 10.1164/rccm.202004-1006OC. Am J Respir Crit Care Med. 2021. PMID: 32857597

References

    1. Badagliacca R, D’Alto M, Ghio S, Argiento P, Bellomo V, Brunetti ND, et al. Risk reduction and hemodynamics with initial combination therapy in pulmonary arterial hypertension Am J Respir Crit Care Med [online ahead of print] 28 Aug2020. DOI: 10.1164/rccm.202004-1006OC. Published in final form as Am J Respir Crit Care Med 2021;203:484–492 (this issue). - PubMed
    1. Boucly A, Weatherald J, Savale L, Jaïs X, Cottin V, Prevot G, et al. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension. Eur Respir J. 2017;50:1700889. - PubMed
    1. Benza RL, Gomberg-Maitland M, Elliott CG, Farber HW, Foreman AJ, Frost AE, et al. Predicting survival in patients with pulmonary arterial hypertension: the REVEAL risk score calculator 2.0 and comparison with ESC/ERS-based risk assessment strategies. Chest. 2019;156:323–337. - PubMed
    1. Weatherald J, Boucly A, Sahay S, Humbert M, Sitbon O. The low-risk profile in pulmonary arterial hypertension: time for a paradigm shift to goal-oriented clinical trial endpoints? Am J Respir Crit Care Med. 2018;197:860–868. - PubMed
    1. Weatherald J, Boucly A, Chemla D, Savale L, Peng M, Jevnikar M, et al. Prognostic value of follow-up hemodynamic variables after initial management in pulmonary arterial hypertension. Circulation. 2018;137:693–704. - PubMed

LinkOut - more resources